Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain Metastases
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Brain Metastases|Generalized Malignancy, Primary|Brain Lesions
Interventions: DRUG: TPI 287|PROCEDURE: Fractionated Stereotactic Radiotherapy (FSRT)
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: Cortice Biosciences, Inc.